Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease

Charles D. Chen, Austin McCullough, Brian A. Gordon, Nelly Joseph‐Mathurin, Shaney Flores, Nicole S. McKay, Diana A. Hobbs, Russ C. Hornbeck, Anne M. Fagan, Carlos Cruchaga, Alison Goate, Richard J. Perrin, Guoqiao Wang, Yan Li, Xinyu Shi, Chengjie Xiong, Michael J. Pontecorvo, Gregory Klein, Yi Su, William E. Klunk, Clifford R. Jack, Robert A. Koeppe, B. Joy Snider, Sarah Berman, Erik D. Roberson, Jared R. Brosch, Ghulam M. Surti, Ivonne Z. Jiménez‐Velázquez, Douglas Galasko, Lawrence S. Honig, William S. Brooks, Roger Clarnette, David Wallon, Bruno Dubois, Jérémie Pariente, Florence Pasquier, Raquel Sánchez‐Valle, Sergey Shcherbinin, Ixavier A. Higgins, Ilke Tunali, Colin L. Masters, Christopher H. van Dyck, Mario Masellis, Ging‐Yuek Robin Hsiung, Serge Gauthier, Steve Salloway, David B. Clifford, Susan Mills, Charlene Supnet, Eric McDade, Randall J. Bateman, Tammie L.S. Benzinger, for the DIAN-TU Study Team